Quesnelle Claude A, Gill Patrice, Dodier Marco, St Laurent Denis, Serrano-Wu Michael, Marinier Anne, Martel Alain, Mazzucco Charles E, Stickle Terry M, Barrett John F, Vyas Dolatrai M, Balasubramanian Balu N
Bristol-Myers Squibb Pharmaceutical Research Institute, 100, boul. de l'Industrie, Candiac, Québec, Canada J5R 1J1.
Bioorg Med Chem Lett. 2003 Feb 10;13(3):519-24. doi: 10.1016/s0960-894x(02)00937-x.
Compounds based on sordaricin were prepared via organometallic addition onto a fully protected sordaricin aldehyde. The fungal growth inhibition profiles for these compounds were established and the results are presented here. The synthesis of homologated sordaricin as well as ether and ester derivatives is presented, and structural rearrangement products upon oxidation. These compounds were evaluated as agents to inhibit fungal growth.